Human longevity assurance protein, its coding sequence and their use
    7.
    发明授权
    Human longevity assurance protein, its coding sequence and their use 失效
    人类长寿保证蛋白,其编码序列及其用途

    公开(公告)号:US07037683B2

    公开(公告)日:2006-05-02

    申请号:US10389222

    申请日:2003-03-14

    IPC分类号: A61K38/17 C07K14/47

    CPC分类号: C07K14/435 A61K38/00

    摘要: The present invention relates to a novel human longevity assurance protein, the polynucleotide encoding the polypeptide and a process for producing the polypeptide by recombinant methods. The present invention also relates to a method of applying the polypeptide for the treatment of various kinds of disease, such as cancer. Further, the present invention relates to the antagonist of the polypeptide and therapeutic use of the same. In addition, the present invention includes the use of the polynucleotide encoding the human longevity assurance protein.

    摘要翻译: 本发明涉及新的人类寿命保证蛋白,编码多肽的多核苷酸和通过重组方法制备多肽的方法。 本发明还涉及应用该多肽治疗各种疾病如癌症的方法。 此外,本发明涉及多肽的拮抗剂及其治疗用途。 此外,本发明包括编码人类寿命保证蛋白质的多核苷酸的用途。

    Anti-EFGRv3 monoclonal antibody
    10.
    发明授权
    Anti-EFGRv3 monoclonal antibody 有权
    抗EFGRv3单克隆抗体

    公开(公告)号:US08506963B2

    公开(公告)日:2013-08-13

    申请号:US13497763

    申请日:2009-09-22

    IPC分类号: A61K39/395 C12P19/34

    摘要: The invention provides specific binding proteins and the uses thereof. Particularly, the present invention provides a monoclonal antibody which can effectively bind to epidermal growth factor receptor variant type III (EGFRvIII) or can partially bind to the epidermal growth factor receptor (EGFR) over-expressed in cells, but not bind to EGFR normally-expressed in cells. Furthermore, the present invention said antibody has obvious therapeutic effect on a tumor cell line expressing the EGFRvIII. The invention also provides a method for preparing said monoclonal antibody and a pharmaceutical composition comprising said monoclonal antibody.

    摘要翻译: 本发明提供特异性结合蛋白及其用途。 特别地,本发明提供了可以有效结合表皮生长因子受体变体III型(EGFRvIII)或可部分结合细胞中过表达的表皮生长因子受体(EGFR)但不与EGFR正常结合的单克隆抗体, 在细胞中表达。 此外,本发明所述抗体对表达EGFRvIII的肿瘤细胞系具有明显的治疗作用。 本发明还提供了制备所述单克隆抗体的方法和包含所述单克隆抗体的药物组合物。